6-47478190-C-CAGG
Position:
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP6_ModerateBS1BS2
The NM_012120.3(CD2AP):c.-55_-54insAGG variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00277 in 1,429,984 control chromosomes in the GnomAD database, including 23 homozygotes. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.0029 ( 1 hom., cov: 33)
Exomes 𝑓: 0.0028 ( 22 hom. )
Consequence
CD2AP
NM_012120.3 5_prime_UTR
NM_012120.3 5_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -0.760
Genes affected
CD2AP (HGNC:14258): (CD2 associated protein) This gene encodes a scaffolding molecule that regulates the actin cytoskeleton. The protein directly interacts with filamentous actin and a variety of cell membrane proteins through multiple actin binding sites, SH3 domains, and a proline-rich region containing binding sites for SH3 domains. The cytoplasmic protein localizes to membrane ruffles, lipid rafts, and the leading edges of cells. It is implicated in dynamic actin remodeling and membrane trafficking that occurs during receptor endocytosis and cytokinesis. Haploinsufficiency of this gene is implicated in susceptibility to glomerular disease. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
BP6
Variant 6-47478190-C-CAGG is Benign according to our data. Variant chr6-47478190-C-CAGG is described in ClinVar as [Likely_benign]. Clinvar id is 357161.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population sas. gnomad4 allele frequency = 0.00289 (440/152050) while in subpopulation SAS AF= 0.0124 (60/4822). AF 95% confidence interval is 0.00992. There are 1 homozygotes in gnomad4. There are 224 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAdExome4 at 22 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CD2AP | NM_012120.3 | c.-55_-54insAGG | 5_prime_UTR_variant | 1/18 | ENST00000359314.5 | NP_036252.1 | ||
CD2AP | XM_005248976.2 | c.-55_-54insAGG | 5_prime_UTR_variant | 1/18 | XP_005249033.1 | |||
CD2AP | XM_017010641.2 | c.-55_-54insAGG | 5_prime_UTR_variant | 1/14 | XP_016866130.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CD2AP | ENST00000359314.5 | c.-55_-54insAGG | 5_prime_UTR_variant | 1/18 | 1 | NM_012120.3 | ENSP00000352264 | P1 | ||
CD2AP-DT | ENST00000604014.2 | upstream_gene_variant |
Frequencies
GnomAD3 genomes AF: 0.00290 AC: 441AN: 151944Hom.: 1 Cov.: 33
GnomAD3 genomes
AF:
AC:
441
AN:
151944
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00275 AC: 3515AN: 1277934Hom.: 22 Cov.: 41 AF XY: 0.00304 AC XY: 1924AN XY: 632244
GnomAD4 exome
AF:
AC:
3515
AN:
1277934
Hom.:
Cov.:
41
AF XY:
AC XY:
1924
AN XY:
632244
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00289 AC: 440AN: 152050Hom.: 1 Cov.: 33 AF XY: 0.00301 AC XY: 224AN XY: 74328
GnomAD4 genome
AF:
AC:
440
AN:
152050
Hom.:
Cov.:
33
AF XY:
AC XY:
224
AN XY:
74328
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Focal segmental glomerulosclerosis Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at